{"data":{"id":"us/21-cfr-524.1195","jurisdiction":"us","citation":"21 CFR 524.1195","heading":"Ivermectin otic suspension.","body":"(a) Specifications. Each tube contains 0.5 milliliter (mL) of a 0.01 percent suspension of ivermectin.\n(b) Sponsor. See No. 000010 in § 510.600(c) of this chapter.\n(c) Conditions of use—(1) Amount. Administer the contents of one 0.5-mL tube topically into each external ear canal.\n(2) Indications for use. For the treatment of adult ear mite (Otodectes cynotis) infestations in cats and kittens 4 weeks of age and older. Effectiveness against eggs and immature stages has not been proven.\n(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER E—ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS","PART 524—OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"328df04ce9299129dc5783b1fde3ff751932a65f8a7abc30a1447e6d688df1d3","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-524.1193","next":"us/21-cfr-524.1200"},"notice":"GroundRules: Original legal text. Not legal advice."}